Dublin, Jan. 23, 2017 -- Research and Markets has announced the addition of the "Carotenoids Market Analysis By Source (Natural, Synthetic), By Product (Beta-Carotene, Lutein, Lycopene, Astaxanthin, Zeaxanthin, Canthaxanthin), By Application (Food, Supplements, Feed, Pharmaceuticals, Cosmetics), And Segment Forecasts, 2014 - 2025" report to their offering.
The global carotenoids market is expected to reach USD 1.74 billion by 2025
The growing application in human food, animal feed, dietary supplements, medicines, and cosmetic application owing to the presence of essential nutrients and vitamins in carotenoids will drive growth over the upcoming years. Furthermore, the increasing demand for these applications on account of population growth, increasing consumer surplus, and health awareness will aid in the industry expansion.
The usage of these products in the pharmaceutical sector will witness substantial revenue growth at a CAGR of 4.3% from 2016 to 2025. These products act as antioxidants within the body and protect the body against chronic diseases, cellular damage, and the effects of aging.
Carotenoids aid in supporting eye, skin, cardiovascular health, and are being widely used for cancer prevention. Strong growth of pharmaceutical and cosmetic industry in emerging countries such as China, India, and South Korea will create growth opportunities for the market in the future.
Further key findings from the report suggest:
- Global carotenoids market demand was 1,150.4 tons in 2015 and is expected to grow significantly on account of increasing demand for human nutrition and skin care cosmetics in emerging countries such as China, India, South Korea, Brazil, Singapore, and Thailand
- Europe accounted for 42% of the global volume share in 2015 and is projected to foresee growth on account of rising usage of the product in functional and processed food products over the upcoming years.
- The rising demand for functional and processed food owing to busy lifestyles is expected to positively impact market growth. Moreover, the presence of major pharmaceutical companies such as GlaxoSmithKline, Pfizer, Sanofi, and Novo Nordisk will drive the demand over the forecast period.
- Natural sources are expected to witness substantial revenue growth at a CAGR of 6.1% from 2016 to 2025 owing to increasing consumer preference for natural products over synthetic products. Natural carotenoids are safe sources of vitamin A which are essential for growth, cellular reproduction, vision, and immunity, which in turn, will witness considerable growth.
The industry is dominated by key participants including
- BASF SE
- Allied Biotech
- Kemin Industries
- Brenntag
- ExcelVite Sdn. Bhd.
- Cyanotech Corp.
- Chr. Hansen
- D. D. Williamson
- DSM Nutritional Products
- Divis Laboratories
- Naturex SA,
- Lycored
Key Topics Covered:
1. Methodology and Scope
2. Executive Summary
3. Carotenoids Market Variables, Trends & Scope
4. Carotenoids Market: Source Estimates & Trend Analysis
5. Carotenoids Market: Product Estimates & Trend Analysis
6. Carotenoids Market: Application Estimates & Trend Analysis
7. Carotenoids Market: Regional Estimates & Trend Analysis
8. Competitive Landscape
9. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/px3h9g/carotenoids
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Food Ingredients , Food Additive Chemicals


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Samsung Electronics Shares Jump on HBM4 Mass Production Report
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Anta Sports Expands Global Footprint With Strategic Puma Stake
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



